| 000 | 01446 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516093929.0 | ||
| 264 | 0 | _c20130708 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1365-2036 | ||
| 024 | 7 |
_a10.1111/j.1365-2036.2012.05154.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTack, G J | |
| 245 | 0 | 0 |
_aTioguanine in the treatment of refractory coeliac disease--a single centre experience. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cAug 2012 |
||
| 300 |
_a274-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadverse effects |
| 650 | 0 | 4 |
_aCeliac Disease _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGuanine Nucleotides _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aThioguanine _xadverse effects |
| 650 | 0 | 4 |
_aThionucleotides _xblood |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _avan Asseldonk, D P | |
| 700 | 1 | _avan Wanrooij, R L J | |
| 700 | 1 | _avan Bodegraven, A A | |
| 700 | 1 | _aMulder, C J | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 36 _gno. 3 _gp. 274-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2036.2012.05154.x _zAvailable from publisher's website |
| 999 |
_c21821630 _d21821630 |
||